Propranolol Should NOT Be Used for Anxiety Attacks in a 16-Year-Old Female
Based on current evidence, propranolol is not recommended for treating anxiety attacks in adolescents. The most authoritative guideline for this age group—the 2020 American Academy of Child and Adolescent Psychiatry Clinical Practice Guideline—identifies cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) as the only treatments with "considerable empirical support as safe and effective" for anxiety in children and adolescents 1. SNRIs have "some empirical support" as an additional option 1. Propranolol is notably absent from these evidence-based recommendations.
Why Propranolol Is Not Recommended
Lack of Efficacy Evidence
The most recent systematic review and meta-analysis (2025) examining beta-blockers for anxiety disorders found no evidence for a beneficial effect of beta-blockers compared with either placebo or benzodiazepines in patients with social phobia or panic disorder (p ≥ 0.54 for all analyses) 2. An earlier 2016 meta-analysis similarly concluded that "the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders" 3.
Pediatric Safety Concerns
The FDA label explicitly states: "Safety and effectiveness of propranolol in pediatric patients have not been established" 4. More concerning, bronchospasm and congestive heart failure have been reported with propranolol administration in pediatric patients 4. This represents a significant safety signal in this age group.
Limited Appropriate Use Cases
Propranolol has demonstrated utility only for performance anxiety (stage fright) in situational contexts—not for generalized anxiety attacks 5, 6. The mechanism involves blocking peripheral somatic symptoms (tremor, tachycardia) rather than treating the underlying anxiety disorder. This is fundamentally different from treating recurrent anxiety attacks.
What TO Use Instead
First-line treatment: Cognitive-behavioral therapy (CBT) alone or combined with an SSRI for moderate-to-severe anxiety 1
Pharmacologic options with evidence in adolescents:
- SSRIs (fluoxetine, sertraline, fluvoxamine) - first-line medication
- SNRIs (venlafaxine, duloxetine) - second-line option
Critical Caveats
- If propranolol is being considered for isolated performance anxiety (e.g., test-taking, public speaking), this represents a different clinical scenario than "anxiety attacks" and may have limited situational use at 10-20 mg taken 30-60 minutes before the event
- Screen for contraindications: asthma, bradycardia, heart block, hypotension
- The older literature suggesting benefit 6 predates modern diagnostic criteria and has not been replicated in rigorous trials 2, 3
- Prescribing propranolol for anxiety in adolescents represents off-label use without supporting evidence 5
The evidence is clear: stick with guideline-recommended treatments (CBT and SSRIs) that have demonstrated efficacy and safety in this population 1.